Astera Labs (NASDAQ:ALAB) Trading Up 5.4% – What’s Next?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price traded up 5.4% during mid-day trading on Monday . The stock traded as high as $440.99 and last traded at $439.66. 5,545,140 shares changed hands during trading, a decline of 3% from the average daily volume of 5,704,791 shares. The stock had previously closed at $417.07.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Morgan Stanley raised their price objective on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Barclays increased their target price on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. UBS Group assumed coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target on the stock. Finally, Evercore reaffirmed an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Stock Up 5.4%

The company has a market cap of $75.36 billion, a P/E ratio of 297.07, a PEG ratio of 5.52 and a beta of 3.94. The firm’s 50 day moving average is $264.43 and its two-hundred day moving average is $187.49.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Buying and Selling

In other news, General Counsel Philip Mazzara sold 796 shares of the firm’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the transaction, the general counsel directly owned 103,343 shares in the company, valued at $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 28,737 shares of Astera Labs stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the transaction, the chief executive officer directly owned 3,789,232 shares in the company, valued at approximately $945,868,091.84. This represents a 0.75% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 2,161,256 shares of company stock valued at $459,844,296. Corporate insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Hedge funds have recently bought and sold shares of the company. Atreides Management LP boosted its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. Amundi boosted its stake in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC acquired a new stake in Astera Labs in the third quarter worth $209,599,000. BNP Paribas Financial Markets grew its holdings in Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after purchasing an additional 960,899 shares during the period. Finally, Artisan Partners Limited Partnership bought a new stake in Astera Labs in the fourth quarter valued at $148,980,000. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.